HC Wainwright Comments on Kura Oncology Q2 Earnings
Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – HC Wainwright issued their Q2 2025 earnings estimates for Kura Oncology in a research report issued on Thursday, February 27th. HC Wainwright analyst J. Pantginis anticipates that the company will post earnings of ($0.81) per share for the quarter. HC Wainwright has a “Buy” rating and a […]
Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – HC Wainwright issued their Q2 2025 earnings estimates for Kura Oncology in a research report issued on Thursday, February 27th. HC Wainwright analyst J. Pantginis anticipates that the company will post earnings of ($0.81) per share for the quarter. HC Wainwright has a “Buy” rating and a […]
